USD 27850.14 million
Report ID: SQSG35G2010 | Region: Global | Published Date: April, 2023 | Pages: 165 | Tables: 154 | Figures: 77
Infectious Disease Diagnostics Market size was valued at USD 27850.14 million in 2021 and is poised to grow from USD 29632.56 million in 2022 to USD 49041.76 million by 2030, growing at a CAGR of 6.5% in the forecast period (2023-2030).
Diagnostic tests are critical for disease diagnosis and for improving global health. Traditional infectious disease diagnosis yielded inaccuracies and was time-consuming. Because of this flaw, the Infectious Disease Diagnostics Market has seen the emergence of rapid, accurate, and portable point-of-care testing products. POC testing allows for faster diagnosis of infectious diseases nearby to the patient's location and provides immediate results. Several researchers are now working on multiplex point-of-care diagnostic technologies.
US Infectious Disease Diagnostics Market is poised to grow at a sustainable CAGR for the next forecast year.
Global Market Size
USD 27850.14 million
Largest Segment
Immunodiagnostics
Fastest Growth
Immunodiagnostics
Growth Rate
6.5% CAGR
To get more reports on the above market click here to Buy The Report
The Global Infectious Disease Diagnostics Market is segmented based on Product, Test, Technology, Disease, End-User, and Region. Based on Product market is segmented into Reagents, Kits, Consumables, Instruments, and Software & Services. Based on Test Type it is categorized into Laboratory and POC. Based on Technology the Infectious Disease Diagnostics Market is segmented into Immunodiagnostics, Microbiology, PCR, NGS, and INAAT. By Disease the market is categorized into COVID-19, Hepatitis, HAI, HIV, Influenza, CT/NG, HPV, TB, and Other Infectious Diseases. By End User, the Infectious Disease Diagnostics Market studied is segmented into Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, and Other End Users. Based on the Region it is categorized into North America, Europe, Asia-Pacific, South America, and MEA.
Infectious Disease Diagnostics Market Analysis by Product
The reagents, kits, and consumables segment held the largest share of this market in 2021. This segment's market growth is driven by the frequent purchase of these products due to their frequent usage. The global prevalence of infectious diseases and the onset of COVID-19, as well as growing awareness for early disease diagnosis, a shift in focus from centralized laboratories to decentralized POC testing, and rising technological advancements are driving the Infectious Disease Diagnostics Market growth.
Infectious Disease Diagnostics Market Analysis by Technology
The immunodiagnostics segment held the largest share in 2021. This is due to the increased use of immunoassays in COVID-19 testing, point-of-care infectious disease testing, the development of novel immunodiagnostic tests, and the rising trend of automation. The growth is attributed to an increase in the number of genomic projects, a surge in DNA sequencing awareness, and advancements in R&D for DNA analysis activities.
To get detailed analysis on other segments, Request For Sample Report
North America held the largest share of the global infectious disease diagnostics market in 2021. The growth of the North American infectious disease diagnostics market can be attributed to the highly developed healthcare systems in the United States and Canada, the presence of many leading national clinical laboratories, and the ease of access to technologically advanced instruments. Within North America, the United States has held a large market share. The increasing prevalence of infectious diseases, high healthcare expenditure, and increased population awareness about the availability of treatment devices are the major factors driving the Infectious Disease Diagnostics Market growth.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Infectious Disease Diagnostics Market Driver
Infectious Disease Diagnostics Market Restraint
Speak to one of our ABIRAW analyst for your custom requirements before the purchase of this report
The Infectious Disease Diagnostics Market is highly fragmented, with the presence of several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. Some of the key players in the Infectious Disease Diagnostics Market are Veracyte Inc., Abbott Laboratories Danaher Corporation, BioMérieux SA, F. Hoffmann-La Roche Ltd, and Becton, Dickinson, and Company.
Infectious Disease Diagnostics Market Top Player’s Company Profiles
Infectious Disease Diagnostics Market Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.
According to our analysis, the increasing prevalence of influenza and related chronic diseases, increased research and development activities in infectious disease diagnostics technologies, growing awareness for early detection using specific diagnostic tests, and other factors are driving the Global Infectious Disease Diagnostics Market. Developing economies such as India, South Korea, Brazil, and Mexico are expected to provide opportunities for growth for major players in the infectious disease diagnostics market. This can be attributed to these countries' high disease prevalence, large patient population, improved healthcare infrastructure, rising disposable income, and growing medical tourism.
Report Metric | Details |
---|---|
Market size value in 2021 | USD 27850.14 million |
Market size value in 2030 | USD 29632.56 million |
Growth Rate | 6.5% |
Base year | 2021 |
Forecast period | 2023-2030 |
Forecast Unit (Value) | USD Million |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Global Infectious Disease Diagnostics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Infectious Disease Diagnostics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Infectious Disease Diagnostics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Global Infectious Disease Diagnostics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Our industry expert will work with you to provide you with customized data in a short amount of time.
SPEAK TO AN ANALYSTGet lifetime access to our reports
Basic Plan $5,000 Team Plan $10,000 SUBSCRIBE NOWThe Global Infectious Disease Diagnostics Market was valued at USD 27.89 Billion in 2021, and it is expected to reach a value of USD 44.46 Billion by 2028, at a CAGR of 6.89% over the forecast period (2022 - 2028).
The Infectious Disease Diagnostics Market is highly fragmented, with the presence of several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. Some of the key players in the Infectious Disease Diagnostics Market are Veracyte Inc., Abbott Laboratories Danaher Corporation, BioMérieux SA, F. Hoffmann-La Roche Ltd, and Becton, Dickinson, and Company.'Abbott Laboratories (US)','F. Hoffmann-La Roche Ltd (Switzerland)','BioMérieux SA (France)','Thermo Fisher Scientific Inc. (US)','Danaher Corporation (US)','Quidel Corporation(US)','Hologic, Inc. (US)','Siemens Healthineers AG (Germany)','Becton, Dickinson, and Company (US)','PerkinElmer Inc. (US)','QIAGEN (Netherlands)','Grifols S.A. (Spain)','DiaSorin S.p.A (Italy)','Bio-Rad Laboratories, Inc. (US)','Sysmex Corporation (Japan)','Ortho Clinical Diagnostics (US)','Luminex Corporation (US)','Meridian Bioscience (US)','Danaher Corporation (US)','Mesa Biotech (US)'
The prevalence of infectious diseases in developed and developing regions will have a positive impact on the infectious disease diagnostics market. The increasing number of prescriptions for infectious disease diagnostic tests is attributable to the diagnosis and management of such diseases. These factors, combined with the growing trend toward preventive medicine, are expected to drive demand for infectious disease diagnostics over the forecast period.
Despite the enormous efforts put into infectious disease management, the development of low-cost, accurate, and sensitive POC products is in high demand. Nanotechnology has paved the way for widespread use in the healthcare industry. Several players have emphasized the introduction of POC platforms based on nanoparticles and Nanodevices.
North America held the largest share of the global infectious disease diagnostics market in 2021. The growth of the North American infectious disease diagnostics market can be attributed to the highly developed healthcare systems in the United States and Canada, the presence of many leading national clinical laboratories, and the ease of access to technologically advanced instruments. Within North America, the United States has held a large market share. The increasing prevalence of infectious diseases, high healthcare expenditure, and increased population awareness about the availability of treatment devices are the major factors driving the Infectious Disease Diagnostics Market growth.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Product ID: SQSG35G2010